Comparison of All-Cause and Cause-Specific Mortality of Persons with Traumatic Spinal Cord Injuries to the General Swiss Population: Results from a National Cohort Study.


Journal

Neuroepidemiology
ISSN: 1423-0208
Titre abrégé: Neuroepidemiology
Pays: Switzerland
ID NLM: 8218700

Informations de publication

Date de publication:
2019
Historique:
received: 24 10 2018
accepted: 12 01 2019
pubmed: 15 2 2019
medline: 26 12 2019
entrez: 15 2 2019
Statut: ppublish

Résumé

Traumatic spinal cord injuries (TSCI) are a neurological condition associated with reduced well-being, increased morbidity and reductions in life expectancy. Estimates of all-cause and cause-specific mortality can aid in identifying targets for prevention and management of contributors for premature mortality. To compare all-cause and cause-specific rates of mortality to that of the Swiss general population; to identify differentials in risk of cause-specific mortality according to lesion characteristics. All-cause and cause-specific standardized mortality ratios (SMRs) were calculated using data from the Swiss Spinal Cord Injury cohort study. Cause-specific subhazard ratios were estimated within a competing risk framework using flexible parametric survival models. Between 1990 and 2011, 2,492 persons sustained a TSCI, of which 379 died. Persons with TSCI had a mortality rate more than 2 times higher than that of the Swiss general population (SMR 2.32; 95% CI 2.10-2.56). Tetraplegic lesions were associated with an increased risk of mortality due to respiratory and cardiovascular diseases, infections, and accidents. Cause-specific SMRs were notably elevated for SCI-related conditions such as urinary tract infections (UTIs) and septicemia. Elevated SMRs due to cardiovascular disease, UTIs and septicemia-related mortality suggest the need for innovation when managing associated secondary health conditions.

Sections du résumé

BACKGROUND
Traumatic spinal cord injuries (TSCI) are a neurological condition associated with reduced well-being, increased morbidity and reductions in life expectancy. Estimates of all-cause and cause-specific mortality can aid in identifying targets for prevention and management of contributors for premature mortality.
OBJECTIVES
To compare all-cause and cause-specific rates of mortality to that of the Swiss general population; to identify differentials in risk of cause-specific mortality according to lesion characteristics.
METHODS
All-cause and cause-specific standardized mortality ratios (SMRs) were calculated using data from the Swiss Spinal Cord Injury cohort study. Cause-specific subhazard ratios were estimated within a competing risk framework using flexible parametric survival models.
RESULTS
Between 1990 and 2011, 2,492 persons sustained a TSCI, of which 379 died. Persons with TSCI had a mortality rate more than 2 times higher than that of the Swiss general population (SMR 2.32; 95% CI 2.10-2.56). Tetraplegic lesions were associated with an increased risk of mortality due to respiratory and cardiovascular diseases, infections, and accidents. Cause-specific SMRs were notably elevated for SCI-related conditions such as urinary tract infections (UTIs) and septicemia.
CONCLUSIONS
Elevated SMRs due to cardiovascular disease, UTIs and septicemia-related mortality suggest the need for innovation when managing associated secondary health conditions.

Identifiants

pubmed: 30763935
pii: 000496976
doi: 10.1159/000496976
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-213

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Jonviea D Chamberlain (JD)

Swiss Paraplegic Research, Nottwil, Switzerland, jonviea.chamberlain@paraplegie.ch.
University of Lucerne, Health Sciences and Health Policy, Luzern, Switzerland, jonviea.chamberlain@paraplegie.ch.
Institute of Social and Preventative Medicine, University of Bern, Bern, Switzerland, jonviea.chamberlain@paraplegie.ch.

Anne Buzzell (A)

Swiss Paraplegic Research, Nottwil, Switzerland.
University of Lucerne, Health Sciences and Health Policy, Luzern, Switzerland.

Hans Peter Gmünder (HP)

Swiss Paraplegic Center, Nottwil, Switzerland.

Kerstin Hug (K)

REHAB Basel, Basel, Switzerland.

Xavier Jordan (X)

Clinique Romande de Réadaptation, Sion, Switzerland.

André Moser (A)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zürich, Switzerland.

Martin Schubert (M)

Balgrist University Hospital, Zürich, Switzerland.

Marcel Zwahlen (M)

Institute of Social and Preventative Medicine, University of Bern, Bern, Switzerland.

Martin W G Brinkhof (MWG)

Swiss Paraplegic Research, Nottwil, Switzerland.
University of Lucerne, Health Sciences and Health Policy, Luzern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH